Drug
Mifamurtide
Mifamurtide is a pharmaceutical drug with 3 clinical trials. Currently 1 active trials ongoing.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Completion Rate
0%(0/2)
Active Trials
1(33%)
Terminated
2(67%)
Phase Distribution
Ph phase_2
2
67%
Phase Distribution
0
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution2 total trials
Phase 2Efficacy & side effects
2(100.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
0.0%
0 of 2 finished
Non-Completion Rate
100.0%
2 ended early
Currently Active
1
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Terminated(2)
Detailed Status
Terminated2
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
1
Success Rate
0.0%
Most Advanced
Phase 2
Trials by Phase
Phase 22 (100.0%)
Trials by Status
terminated267%
active_not_recruiting133%
Recent Activity
1 active trials
Showing 3 of 3
active_not_recruitingphase_2
Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients
NCT03643133
terminatedphase_2
A Eurosarc Study of Mifamurtide in Advanced Osteosarcoma (MEMOS)
NCT02441309
terminated
Surveillance Study of Patients With Newly Diagnosed Osteosarcoma
NCT01194284
Clinical Trials (3)
Showing 3 of 3 trials
NCT03643133Phase 2
Mifamurtide Combined With Post-operative Chemotherapy for Newly Diagnosed High Risk Osteosarcoma Patients
NCT02441309Phase 2
A Eurosarc Study of Mifamurtide in Advanced Osteosarcoma (MEMOS)
NCT01194284
Surveillance Study of Patients With Newly Diagnosed Osteosarcoma
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3